Literature DB >> 2018483

Radiation-inactivation size of transformed and non-transformed androgen receptors.

G Turcotte1, G Beauregard, M Potier, S Chevalier.   

Abstract

The nucleic acid sequence of the androgen receptor (AR) gene predicts that the protein structure possesses DNA- and steroid-binding domains that show high degrees of sequence similarity with those of other steroid receptors. Since the steroid-binding domain of the AR corresponds to a 30 kDa portion of the protein, and the AR structure may be monomeric or hetero-oligomeric depending on its transformation state, we have herein determined the AR radiation-inactivation size (RIS) in relation to the molecular structure whose binding activity toward methyltrienolone (R1881) is abolished by a radiation 'hit'. Soluble fractions from whole canine prostatic tissue were used as a source of non-transformed AR. The AR transformation was induced by the addition of 0.6 M-KCl, and these preparations were used together with high-salt nuclear extracts as a source of transformed AR. To maximize the binding activity, molybdate and dithiothreitol were included during AR extraction. Receptor transformation was verified by modifications of both the sedimentation coefficients (from 7.5 S to 4.1 S on sucrose gradients) and molecular masses (from 260 kDa to 115 kDa by gel filtration). The RIS values of the non-transformed and transformed ARs were not statistically different: 92 +/- 19 kDa and 110 +/- 25 kDa respectively. In addition, the inactivation of AR binding activity by radiation was attributed to a loss of binding sites, with no significant change in the Kd. When benzoic acid, a free-electron scavenger, was added together with dithiothreitol before and after irradiation, no change in the RIS value was observed. Thus, in the canine prostate, the RIS value of the AR represents the monomeric protein, independently of its association with other proteins, and this value corresponds to that predicted by cloning studies and photoaffinity-labelling of AR.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018483      PMCID: PMC1150010          DOI: 10.1042/bj2750041

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  A fine-structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterization of alkaline phosphatase.

Authors:  A GAREN; C LEVINTHAL
Journal:  Biochim Biophys Acta       Date:  1960-03-11

2.  Identification of limited capacity androgen binding components in nuclear and cytoplasmic fractions of canine prostate.

Authors:  R W Boesel; R W Klipper; S A Shain
Journal:  Endocr Res Commun       Date:  1977

3.  Androgen receptor assay with [3H]methyltrienolone (R1881) in the presence of progesterone receptors.

Authors:  D T Zava; B Landrum; K B Horwitz; W L McGuire
Journal:  Endocrinology       Date:  1979-04       Impact factor: 4.736

4.  Binding of androgens in dog prostate cytosol and in plasma.

Authors:  J Y Dubé; R R Tremblay; F T Dionne; P Chapdelaine
Journal:  J Steroid Biochem       Date:  1979-04       Impact factor: 4.292

5.  Membrane enzyme systems. Molecular size determinations by radiation inactivation.

Authors:  G R Kepner; R I Macey
Journal:  Biochim Biophys Acta       Date:  1968-09-17

6.  Radiation inactivation of enzymes at low dose rates: identical molecular weights of rat liver cytosolic and lysosomal neuraminidases.

Authors:  G Beauregard; M Potier
Journal:  Anal Biochem       Date:  1982-05-15       Impact factor: 3.365

7.  Androgen levels in the lipid of the canine vas deferens and peripheral plasma.

Authors:  P Boulanger; M Desaulniers; G M Dupuy; G Bleau; K D Roberts; A Chapdelaine
Journal:  J Endocrinol       Date:  1982-04       Impact factor: 4.286

8.  Effect of molybdate on androgen receptor levels in canine prostate.

Authors:  W Y Naritoku; E B Howard; J O Britt; F S Markland
Journal:  Prostate       Date:  1982       Impact factor: 4.104

9.  Activation of thymocyte glucocorticoid receptors to the steroid binding form. The roles of reduction agents, ATP, and heat-stable factors.

Authors:  J J Sando; N D Hammond; C A Stratford; W B Pratt
Journal:  J Biol Chem       Date:  1979-06-10       Impact factor: 5.157

10.  Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.

Authors:  M Menon; C E Tananis; L L Hicks; E F Hawkins; M G McLoughlin; P C Walsh
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.